Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Polymedco Joins CancerX to Accelerate Innovation in Cancer Detection and Diagnosis | ||
| By: PR Newswire Association LLC. - 30 Jan 2024 | Back to overview list |
|
|
CORTLANDT MANOR, N.Y., Jan. 30, 2024 /PRNewswire/ -- Polymedco, a leading provider of best-in-class colorectal cancer screening and early detection solutions, is proud to announce its membership in CancerX, a public-private partnership founded as part of the White House's Cancer Moonshot initiative. CancerX is an exclusive network of industry leaders, researchers, and innovators dedicated to advancing the field of cancer research and diagnostics.
Polymedco is proud to announce its membership in CancerX, part of the White House's Cancer Moonshot initiative. Polymedco's partnership with CancerX reflects both organizations' commitment to fostering innovation, collaboration, and excellence in the pursuit of earlier cancer detection, diagnosis, and treatment. "Polymedco is honored to join CancerX and work alongside some of the brightest minds in healthcare and innovative companies. This partnership is a significant step toward Polymedco's ultimate goal of saving more lives through broader awareness and expansion of affordable testing to enable early cancer detection." said Doug White CEO at Polymedco. As a member, Polymedco looks forward to contributing to the goal of saving more lives through early detection, by working to help expand access to screening and support patients and caregivers. "We're pleased to partner with Polymedco, as part of CancerX, in applying digital innovation to the fight against cancer," said Doug Mirsky, Vice President, Digital Medicine Society. "Through this powerful public-private partnership with our government partners and CancerX members, like Polymedco, we are uniquely suited to address challenges that are impossible for other efforts to impact and deliver demonstrable improvements to people living with and surviving cancer." This partnership marks a significant milestone in Polymedco's commitment to making early detection more effective, accessible, and affordable. By collaborating with other influential members of CancerX, Polymedco will actively work to drive progress in the development of advanced diagnostic tools and methodologies. Together, we will unleash the power of innovation to fight cancer. About Polymedco: About CancerX: For more ways to partner with Polymedco, please contact Anthony Bercaw.
SOURCE Polymedco, LLC 
|
||
|
||
 | Back to overview list | |
View original content to download multimedia: